Article

Bausch & Lomb offers aberration-free accommodating IOL with aspheric optics

Bausch & Lomb has announced the launch of the first aberration-free accommodating IOL with aspheric optics (Crystalens AO) to cataract surgeons worldwide.

Aliso Viejo, CA

-Bausch & Lomb has announced the launch of the first aberration-free accommodating IOL with aspheric optics (Crystalens AO) to cataract surgeons worldwide.

The lens has prolate aspheric surfaces and is designed to be free of spherical aberration, the company said in a prepared statement. The IOL is designed to improve retinal image quality without compromising depth of field and, therefore, it provides greater quality of distance and intermediate vision, according to a company statement.

“Some surgeons might assume because the Crystalens has aspheric optics, depth of field will be reduced. However, our comprehensive testing demonstrates the opposite to be true,” said Andy Corley, global president, Surgical, Bausch & Lomb. “Not all aspheric lenses are created the same, and other aspheric IOLs have negative spherical aberration, which could reduce depth of field. The Crystalens AO has zero spherical aberration, and the combination of the Crystalens platform and AO optics work[s] together to enhance depth of field.”

“We know that many surgeons prefer aspheric lenses because they believe that they correct for spherical aberrations and provide better quality of vision,” said Amy Jacobs, director of global marketing for the Crystalens.

The aspheric optic lens is composed of proprietary biosil silicone and has a thin and uninterrupted barrier edge. It will be inserted using an injector (CI-28) in a controlled manner through an unenlarged phaco incision, a routine requirement in today’s cataract surgical procedure.

The worldwide launch of the IOL is expected to accelerate through the first quarter of 2010, according to the company.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.